HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of peptides that bind the tumor-associated Thomsen-Friedenreich antigen selected from bacteriophage display libraries.

Abstract
Peptides with high affinities and specificities for numerous proteins and nucleic acids have been previously identified from random peptide bacteriophage display libraries. Here, random peptide bacteriophage display libraries were used to identify sequences that bound the cancer-associated Thomsen-Friedenreich glycoantigen (T antigen). The T antigen, present on most malignant cells, contains an immunodominant Gal beta1 --> 3GalNAc alpha disaccharide unmasked on the surfaces of most carcinomas. This antigen has been postulated to be involved in tumor cell aggregation and metastasis. Two 15 amino acid random peptide bacteriophage display libraries were affinity selected with glycoproteins displaying T antigen on their surfaces. Sequence analysis revealed that many of the peptides shared homology with sugar recognition sites in several carbohydrate-binding proteins. A comparison of affinity selected sequences from both libraries yielded a common motif (W-Y-A-W/F-S-P) rich in aromatic amino acids. Four peptides, corresponding to the affinity selected sequences, were chemically synthesized and characterized for their carbohydrate recognition properties. The synthetic peptides exhibited high specificities and affinities to T antigen displayed on asialofetuin or conjugated to bovine serum albumin (Kd = 5 nM for MAP-P30 binding to asialofetuin) as well as free T-antigen disaccharide in solution (Kd = 10 microM for MAP-P30, 20 microM for P10). Two peptides, P30 and P10, demonstrated high affinities and specificities for both asialofetuin and T antigen in solution. Iodination of a lone tyrosine residue in each sequence dramatically reduced their abilities to bind T antigen, suggesting that the tyrosine residue plays an important role in carbohydrate recognition. That these peptides are of functional significance is evidenced by the ability of both P30 and P10 to inhibit asialofetuin-mediated melanoma cell aggregation in vitro and to compete with peanut lectin for binding to T antigen displayed on the surface of MDA-MB-435 breast carcinoma cells in situ.
AuthorsE N Peletskaya, V V Glinsky, G V Glinsky, S L Deutscher, T P Quinn
JournalJournal of molecular biology (J Mol Biol) Vol. 270 Issue 3 Pg. 374-84 (Jul 18 1997) ISSN: 0022-2836 [Print] Netherlands
PMID9237904 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antigens, Neoplasm
  • Antigens, Tumor-Associated, Carbohydrate
  • Asialoglycoproteins
  • Fetuins
  • Lectins
  • Peanut Agglutinin
  • Peptide Library
  • Peptides
  • alpha-Fetoproteins
  • asialofetuin
  • Serum Albumin, Bovine
  • Thomsen-Friedenreich antigen
  • Tyrosine
Topics
  • Amino Acid Sequence
  • Animals
  • Antigens, Neoplasm (metabolism)
  • Antigens, Tumor-Associated, Carbohydrate (metabolism)
  • Asialoglycoproteins (metabolism)
  • Binding, Competitive
  • Breast Neoplasms (metabolism)
  • Carcinoma (metabolism)
  • Cell Aggregation
  • Fetuins
  • Humans
  • Lectins (metabolism)
  • Melanoma (pathology)
  • Mice
  • Molecular Sequence Data
  • Peanut Agglutinin
  • Peptide Library
  • Peptides (chemical synthesis, metabolism)
  • Protein Binding
  • Sequence Homology, Amino Acid
  • Serum Albumin, Bovine
  • Tumor Cells, Cultured
  • Tyrosine (metabolism)
  • alpha-Fetoproteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: